EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.
RIVM research basis for historic climate agreement on HFCs Scientific research by RIVM’s Guus Velders stood partly at the basis of the HFC global climate agreement.
Documentary Sea Blind on Dutch Television Sea Blind is a documentary about the impact of shipping on the environment, especially on the Arctic Sea.
Shortcomings in technical documentation of both existing and new blood glucose meters RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.
RIVM launches new web-based version of ConsExpo An improved version of the computer program ConsExpo is now available via the RIVM website.
International attention for innovative approach sustainably managed landfills RIVM and ECN have published a novel approach for calculating acceptable emissions from sustainably managed landfills. With these emissions, landfills no longer require perpetual aftercare.
Increase in excise taxes on alcohol can yield 14 to 20 billion euros in societal benefits An increase in excise taxes of 50 per cent over a period of fifty years will result in societal benefits of 14 to 20 billion euro in the Netherlands.
Less air pollution from traffic and industry but increased contribution from agriculture International air policy has shown good results in Europe: in the past 35 years the air has become cleaner. Nevertheless air pollution is still an important cause of premature death.
Early detection of work-related health risks in Europe At European level, different methods are used to identify substances and processes that may cause cancer as early as possible, the so-called early warning systems.
Burden of disease and societal costs of work-related cancer in the European Union Yearly approximately 122,600 people in the EU are diagnosed with cancer, caused by past exposure to carcinogenic substances at work.